Download PDF
Klin Monbl Augenheilkd 2014; 231(08): 830-834
DOI: 10.1055/s-0034-1368433
Kasuistik
Georg Thieme Verlag KG Stuttgart · New York

Die Chorioretinitis centralis serosa und die depressive Störung – eine psychosomatische Perspektive

Central Serous Chorioretinitis and Depressive Disorder – a Psychosomatic Perspective
S. Haisch
1   Klinik für Psychosomatische Medizin und Psychotherapie, University of Ulm, Ulm
,
C. W. Spraul
2   Augenärzte im Basteicenter, Ulm
,
M. Noll-Hussong
1   Klinik für Psychosomatische Medizin und Psychotherapie, University of Ulm, Ulm
› Author Affiliations
Further Information

Publication History

eingereicht 22 November 2013

akzeptiert 03 April 2014

Publication Date:
05 June 2014 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die Chorioretinitis centralis serosa wird in ätiologischen Überlegungen immer wieder mit einem unspezifischen Distresskonzept in Zusammenhang gebracht. Die depressive Störung stellt hingegen einen klar benennbaren, spezifischen Stressor dar, der nicht zuletzt in der Kardiologie wie Diabetologie als bedeutender, eigenständiger Risikofaktor bekannt ist. In vorliegendem Fallbericht wird aus psychosomatischer Sicht die klinische Korrelation zwischen einer Chorioretinitis centralis serosa und einer depressiven Störung aufgezeigt, wobei ein lediglich ad hoc naheliegendes sequenziell-reaktives Störungsverständnis demjenigen einer simultanen Verschränkung gegenübergestellt wird, welches nach unserem Ermessen zu bevorzugen wäre.

Abstract

Central serous chorioretinitis serosa is repeatedly brought into aetiological considerations with a rather unspecific concept of distress. Depressive disorder represents a specific stressor, which is known in cardiology or diabetology as a significant risk factor. In the present case report, the clinical correlation between a central serous chorioretinitis and a depressive disorder is shown from a psychosomatic point of view, comparing a sequentially-reactive understanding of the disorder complex with a preferable model of simultaneous entanglement.

Schlüsselwörter

intraokulare Entzündungen - Pathologie - Retina

Key words

intraocular inflammation - pathology - retina
 

  • Literatur

  • 1 Spahn C, Wiek J, Burger T et al. Psychosomatic aspects in patients with central serous chorioretinopathy. Br J Ophthalmol 2003; 87: 704-708
    CrossrefPubMedGoogle Scholar
  • 2 Wynn PA. Idiopathic central serous chorioretinopathy–a physical complication of stress?. Occup Med (Lond) 2001; 51: 139-140
    CrossrefPubMedGoogle Scholar
  • 3 Conrad R, Bodeewes I, Schilling G et al. [Central serous chorioretinopathy and psychological stress]. Ophthalmologe 2000; 97: 527-531
    CrossrefPubMedGoogle Scholar
  • 4 Gelber GS, Schatz H. Loss of vision due to central serous chorioretinopathy following psychological stress. Am J Psychiatry 1987; 144: 46-50
    CrossrefPubMedGoogle Scholar
  • 5 Lipowski ZJ, Kiriakos RZ. Psychosomatic aspects of central serous retinopathy. A review and case report. Psychosomatics 1971; 12: 398-401
    CrossrefPubMedGoogle Scholar
  • 6 Franke GH, Esser J, Stacker KH et al. [“Filtered normality”: psychological causes and sequelae of specific retinal diseases]. Psychother Psychosom Med Psychol 1996; 46: 159-168
    PubMedGoogle Scholar
  • 7 Liew G, Quin G, Gillies M et al. Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Experiment Ophthalmol 2013; 41: 201-214
    CrossrefPubMedGoogle Scholar
  • 8 Nicholson B, Noble J, Forooghian F et al. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol 2013; 58: 103-126
    CrossrefPubMedGoogle Scholar
  • 9 Ross A, Ross AH, Mohamed Q. Review and update of central serous chorioretinopathy. Curr Opin Ophthalmol 2011; 22: 166-173
    CrossrefPubMedGoogle Scholar
  • 10 Gemenetzi M, de Salvo G, Lotery AJ. Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye 2010; 24: 1743-1756
    CrossrefPubMedGoogle Scholar
  • 11 Gagnier JJ, Kienle G, Altman DG et al. The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol 2014; 67: 46-51
    CrossrefPubMedGoogle Scholar
  • 12 Schnell K, Herpertz SC. Psychotherapy in psychiatry: the current situation and future directions in Germany. Eur Arch Psychiatry Clin Neurosci 2011; 261 (Suppl. 02) S129-S134
    CrossrefPubMedGoogle Scholar
  • 13 Wittchen HU, Wunderlich U, Gruschwitz S et al. Strukturiertes klinisches Interview für DSM-IV, Achse I (SKID). Göttingen: Hogrefe; 1997
    Google Scholar
  • 14 APA. Diagnostic and statistic Manual of mental Disorders. 4th ed. Washington, DC: American Psychiatric Press; 2000
    Google Scholar
  • 15 DIMDI (Deutsches Institut für Medizinische Dokumentation und Information). ICD-10-GM Version 2013. Köln: DIMDI; 2013
    Google Scholar
  • 16 WHO. Internationale Klassifikation psychischer Störungen: ICD-10 Kapitel V (F). Klinisch-diagnostische Leitlinien. 8. Aufl. Bern: Hans Huber; 2011
    CrossrefGoogle Scholar
  • 17 Jain AK, Kaines A, Schwartz S. Bilateral central serous chorioretinopathy resolving rapidly with treatment for obstructive sleep apnea. Graefes Arch Clin Exp Ophthalmol 2010; 248: 1037-1039
    CrossrefPubMedGoogle Scholar
  • 18 Cotticelli L, Borrelli M, DʼAlessio AC et al. Central serous chorioretinopathy and helicobacter pylori. Eur J Ophthalmol 2006; 16: 274-278
    PubMedGoogle Scholar
  • 19 Spalding JM. Central serous chorioretinopathy and HIV. J Am Optom Assoc 1999; 70: 391-398
    PubMedGoogle Scholar
  • 20 Nucci C, Corsi A, Mancino R et al. Central serous chorioretinopathy in patients with psoriasis. Acta Ophthalmol Scand 2004; 82: 105-107
    CrossrefPubMedGoogle Scholar
  • 21 Schreiber JB, Lakhanpal V, Nasrallah SM. Crohnʼs disease complicated by idiopathic central serous chorioretinopathy with bullous retinal detachment. Dig Dis Sci 1989; 34: 118-122
    CrossrefPubMedGoogle Scholar
  • 22 Cunningham jr. ET, Alfred PR, Irvine AR. Central serous chorioretinopathy in patients with systemic lupus erythematosus. Ophthalmology 1996; 103: 2081-2090
    CrossrefPubMedGoogle Scholar
  • 23 Khairallah M, Kahloun R, Tugal-Tutkun I. Central serous chorioretinopathy, corticosteroids, and uveitis. Ocul Immunol Inflamm 2012; 20: 76-85
    CrossrefPubMedGoogle Scholar
  • 24 Yannuzzi LA. Type A behavior and central serous chorioretinopathy. Retina 2012; 32 (Suppl. 01) 709
    PubMedGoogle Scholar
  • 25 Haimovici R, Koh S, Gagnon DR et al. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 2004; 111: 244-249
    CrossrefPubMedGoogle Scholar
  • 26 Tsai DC, Chen SJ, Huang CC et al. Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001–2006: a population-based study. PloS One 2013; 8: e66858
    CrossrefPubMedGoogle Scholar
  • 27 Tittl MK, Spaide RF, Wong D et al. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 1999; 128: 63-68
    CrossrefPubMedGoogle Scholar
  • 28 Chan WM, Lai TY, Tano Y et al. Photodynamic therapy in macular diseases of asian populations: when East meets West. Jpn J Ophthalmol 2006; 50: 161-169
    CrossrefPubMedGoogle Scholar
  • 29 Venkatesh P, Gadia R, Tewari HK et al. Prehypertension may be common in patients with central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1101-1103
    CrossrefPubMedGoogle Scholar
  • 30 Turkcü FM, Yüksel H, Sahin A et al. Effects of smoking on visual acuity of central serous chorioretinopathy patients. Cutan Ocul Toxicol 2013; DOI: 10.3109/15569527.2013.810633.
    PubMedGoogle Scholar
  • 31 Ascaso FJ, Cruz N, Del Buey MA et al. An unusual case of cocaine-induced maculopathy. Eur J Ophthalmol 2009; 19: 880-882
    PubMedGoogle Scholar
  • 32 Piskunowicz M, Jaracz M, Lesiewska H et al. Temperament profile in patients with central serous chorioretinopathy: a case-control study. Eur J Ophthalmol 2014; 24: 392-395
    CrossrefPubMedGoogle Scholar
  • 33 Conrad R, Weber NF, Lehnert M et al. Alexithymia and emotional distress in patients with central serous chorioretinopathy. Psychosomatics 2007; 48: 489-495
    CrossrefPubMedGoogle Scholar
  • 34 Sahin A, Bez Y, Kaya MC et al. Psychological distress and poor quality of life in patients with central serous chorioretinopathy. Semin Ophthalmol 2014; 29: 73-76
    CrossrefPubMedGoogle Scholar
  • 35 Fok AC, Chan PP, Lam DS et al. Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy. Ophthalmic Res 2011; 46: 160-163
    CrossrefPubMedGoogle Scholar
  • 36 Kaiser HJ, Erb C, Flammer J. Augenheilkunde. In: Adler RH, Herzog W, Joraschky P, et al., Hrsg. Uexküll Psychosomatische Medizin: Theoretische Modelle und klinische Praxis. 7. Aufl. München: Urban & Fischer (Elsevier GmbH); 2010: 1127-1135
    Google Scholar
  • 37 Maier M, Stumpfe S, Feucht N et al. [Mineralocorticoid receptor antagonists as treatment option for acute and chronic central serous chorioretinopathy]. Ophthalmologe 2014; 111: 173-180
    CrossrefPubMedGoogle Scholar
  • 38 Rouvas AA, Chatziralli IP, Ladas ID et al. The impact of financial crisis on central serous chorioretinopathy in Greece: is there any correlation?. Eur J Ophthalmol 2013; DOI: 10.5301/ejo.5000403.
    PubMedGoogle Scholar
  • 39 Kitzmann AS, Pulido JS, Diehl NN et al. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980–2002. Ophthalmology 2008; 115: 169-173
    CrossrefPubMedGoogle Scholar
  • 40 Bahrke U, Krause A, Walliser U et al. [Retinopathia centralis serosa–stomach ulcer of ophthalmology?]. Psychother Psychosom Med Psychol 2000; 50: 464-469
    Article in Thieme ConnectPubMedGoogle Scholar
  • 41 Hammen C. Stress and depression. Annu Rev Clin Psychol 2005; 1: 293-319
    CrossrefPubMedGoogle Scholar
  • 42 Hammen C. Generation of stress in the course of unipolar depression. J Abnorm Psychol 1991; 100: 555-561
    CrossrefPubMedGoogle Scholar
  • 43 Lin EH, Rutter CM, Katon W et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care 2010; 33: 264-269
    CrossrefPubMedGoogle Scholar
  • 44 Lippi G, Montagnana M, Favaloro EJ et al. Mental depression and cardiovascular disease: a multifaceted, bidirectional association. Semin Thromb Hemost 2009; 35: 325-336
    Article in Thieme ConnectPubMedGoogle Scholar
  • 45 Rozanski A, Blumenthal JA, Davidson KW et al. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 2005; 45: 637-651
    Google Scholar
  • 46 Huisingh C, McGwin G. Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study. Br J Ophthalmol 2014; 98: 570-571
    CrossrefPubMedGoogle Scholar
  • 47 Tsai DC, Huang CC, Chen SJ et al. Central serous chorioretinopathy and risk of ischaemic stroke: a population-based cohort study. Br J Ophthalmol 2012; 96: 1484-1488
    CrossrefPubMedGoogle Scholar
  • 48 Tsai DC, Huang CC, Chen SJ et al. Increased risk of erectile dysfunction among males with central serous chorioretinopathy – a retrospective cohort study. Acta Ophthalmol 2013; 91: 666-671
    CrossrefPubMedGoogle Scholar
  • 49 Kessing LV. Endogenous, reactive and neurotic depression – diagnostic stability and long-term outcome. Psychopathology 2004; 37: 124-130
    CrossrefPubMedGoogle Scholar
  • 50 Paykel ES. Basic concepts of depression. Dialogues Clin Neurosci 2008; 10: 279-289
    PubMedGoogle Scholar
  • 51 Chung YR, Seo EJ, Lew HM et al. Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review. Eye 2013; 27: 1339-1346
    CrossrefPubMedGoogle Scholar
  • 52 Spahn C, Wiek J, Burger T. [Operationalized psychodynamic diagnostics (OPD) in patients with central serous chorioretinopathy]. Psychother Psychosom Med Psychol 2004; 54: 52-57
    Article in Thieme ConnectPubMedGoogle Scholar
  • 53 Tewari HK, Gadia R, Kumar D et al. Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study. Invest Ophthalmol Vis Sci 2006; 47: 3474-3478
    CrossrefPubMedGoogle Scholar
  • 54 Bernasconi P, Messmer E, Bernasconi A et al. Assessment of the sympatho-vagal interaction in central serous chorioretinopathy measured by power spectral analysis of heart rate variability. Graefes Arch Clin Exp Ophthalmol 1998; 236: 571-576
    CrossrefPubMedGoogle Scholar
  • 55 Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999; 282: 1737-1744
    CrossrefPubMedGoogle Scholar
  • 56 Gräfe K, Zipfel S, Herzog W et al. Screening psychischer Störungen mit dem „Gesundheitsfragebogen für Patienten (PHQ-D)“. Diagnostica 2004; 50: 171-181
    CrossrefPubMedGoogle Scholar